C-reactive protein (CRP) is routinely assessed as a marker of systemic inflammation in
rheumatoid arthritis (RA). However, it is also an immune regulator that plays an important …

Background Biologics are used for the treatment of rheumatoid arthritis and many other
conditions. While the efficacy of biologics has been established, there is uncertainty …

While rheumatologists often focus on treatment targets, for many patients with rheumatoid
arthritis (RA), control over pain and fatigue, as well as sustaining physical function and …

The aim of this review is to provide a summary of adult measures of general health and
health-related quality of life (HRQOL) commonly used in rheumatology research studies …

ABSTRACT Introduction: Psoriatic arthritis (PsA) is a multi-organ chronic inflammatory
disease which impacts patients both physically and psychologically. The highest priority for …

Biological therapies are an effective treatment for a range of immune-mediated inflammatory
diseases (IMIDs), including rheumatoid arthritis, psoriasis, and inflammatory bowel …

Current guidelines for the management of rheumatoid arthritis (RA) recommend early
treatment and a treat-to-target goal of remission or low disease activity. Over the past …

Objective The disease burden in rheumatoid arthritis (RA) extends beyond the joint. This
article evaluates the physical and psychosocial extra-articular burden of treated RA and …

Systemic inflammation is accompanied by profound behavioral and mood changes that
resemble symptoms of depression. Findings in animals suggest that pro-inflammatory …

Background To assess the effect of baricitinib on patient-reported outcomes (PROs) in
patients with active rheumatoid arthritis and an inadequate response to methotrexate (MTX) …